Navigation Links
The 'forgotten epidemic' killing millions

Malaria, the ancient mosquito-borne disease that was rolled back by medical advances in the mid-20th century, is making a deadly comeback.//

Strains of the disease are becoming increasingly resistant to treatment, infecting and killing more people than ever before -- sickening as many as 900 million last year, according to estimates by the U.S. Agency for International Development.

More than 1 million people -- and as many as 2.7 million by some estimates -- of those victims died. The vast majority of the deaths were in Africa.

"Malaria is something that we thought we had conquered years ago. But more and more of our people are dying from it every day," said Patrick Dike, a malaria specialist . Only AIDS kills more people worldwide. Among children, malaria kills even more than AIDS.

The 'forgotten epidemic' killing millions Mosquito-borne malaria making a deadly comeback Malaria, the ancient mosquito-borne disease that was rolled back by medical advances in the mid-20th century, is making a deadly comeback.

Strains of the disease are becoming increasingly resistant to treatment, infecting and killing more people than ever before -- sickening as many as 900 million last year, according to estimates by the U.S. Agency for International Development.

More than 1 million people -- and as many as 2.7 million by some estimates -- of those victims died. The vast majority of the deaths were in Africa.

"Malaria is something that we thought we had conquered years ago. But more and more of our people are dying from it every day," said Patrick Dike, a malaria specialist . Only AIDS kills more people worldwide. Among children, malaria kills even more than AIDS.

Increasing resistance
A major cause of malaria's alarming resurgence is the parasite's increasing resistance to the drugs used to treat and prevent the disease -- including chloroquine, the cheapest and most effective anti-malari al since the 1950s.

The number of alternatives are limited. The WHO supports use of multi-drug combinations based on artemisinin, until recently an extract from the "sweet wormwood" plant used in China for centuries but little known in the West.

Some governments and Western donors have been hesitant to promote the treatment widely because of a lack of funds -- artemisinin is 10 times more expensive than chloroquine, or between $4.50 and $9 for a three-day treatment. "People don't understand why their relatives are sometimes not recovering, or why they are not being cured as quickly as they are used to being cured. How do you explain drug resistance? When they are suffering, the doctor is blamed."
'"/>




Related medicine news :

1. Painkilling Patch As Effective As Intravenous Delivery Systems
2. Terri Schiavo is no more, but the question of Mercy killing is unresolved…
3. Mercy killing for newborn with incurable disease in Netherlands
4. Cancer killing antibody effective against prostate cancer
5. Brain cells by millions die during a stroke
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... 2017 , ... Accreditation Commission for Health Care (ACHC) is ... (HCAOA). This agreement allows HCAOA members to receive special pricing on ACHC’s Home ... University (AU) educational resources that help prepare HCAOA members for ACHC Accreditation. , ...
(Date:4/28/2017)... Clara, CA (PRWEB) , ... April 28, 2017 ... ... is pleased to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep ... user experience, since it streamlines the reporting process and provides a familiar interface ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, ... the GlycoMark test throughout the Northeast U.S. , GlycoMark is the only ... The GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic ...
(Date:4/28/2017)... ... 2017 , ... Ushio America proudly introduces the new ... solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts so ... lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s easy ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... , April 20, 2017 Eyevensys, ... the first non-viral gene expression technology that enables the ... eye to address a wide range of ophthalmic diseases, ... and Healthcare products Regulatory Agency (MHRA) to advance its ... ...
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
Breaking Medicine Technology: